MPWT
JANX icon

MassMutual Private Wealth & Trust’s Janux Therapeutics JANX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6
Closed -$83 – 2452
2026
Q1 		$83 Buy
+6
New +$82 ﹤0.01% 2363

Other funds holding JANX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
S
SimplyRich Carlsbad, California $427M AUM 43.67% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

MassMutual Private Wealth & Trust's JANX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust sold out of Janux Therapeutics (JANX) in Q2 2026, closing a stake of 6 shares — an estimated $83 sold.

MassMutual Private Wealth & Trust first reported a position in JANX in Q1 2026 and held it in 1 quarter. The position peaked at $83 in Q1 2026. 33 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • MassMutual Private Wealth & Trust reported no remaining Janux Therapeutics position as of Q2 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 6 Janux Therapeutics shares in Q2 2026, an estimated $83.
  • MassMutual Private Wealth & Trust first reported a position in Janux Therapeutics in Q1 2026 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Janux Therapeutics position peaked at $83 in Q1 2026.
  • 33 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.